Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Haemophilia. 2009 Jul;15(4):952-8. doi: 10.1111/j.1365-2516.2009.02020.x. Epub 2009 Apr 7.

Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline.

Author information

  • 1Van Creveldkliniek/Department of Haematology, University Medical Center Utrecht, Heidelberglaan 100, PO Box 85500, Utrecht 3508 GA, The Netherlands. r.schutgens@umcutrecht.nl

Abstract

Since the introduction of clotting factor concentrates, life expectancy of haemophilia patients is increasing and now approaches that of the general male population. Increasingly, haemophilia patients are confronted with age-related co-morbidity, including ischaemic cardiovascular disease. Treatment of stable angina pectoris and the acute coronary syndrome with antithrombotic therapy and percutaneous coronary intervention in haemophilia patients is feasible, but requires a tight co-operation between all specialists involved. As evidence-based guidelines are lacking, we developed a protocol on how we will treat haemophilia patients with ischaemic heart disease.

PMID:
19473421
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk